ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 102 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $448,000 | +58.9% | 4,824 | +2.0% | 0.02% | +50.0% |
| Q3 2021 | $282,000 | -12.7% | 4,729 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $323,000 | -1.5% | 4,729 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $328,000 | -12.3% | 4,729 | -2.9% | 0.01% | -23.5% |
| Q4 2020 | $374,000 | +1.9% | 4,870 | -0.7% | 0.02% | 0.0% |
| Q3 2020 | $367,000 | +18.8% | 4,905 | 0.0% | 0.02% | +13.3% |
| Q2 2020 | $309,000 | +62.6% | 4,905 | +8.4% | 0.02% | +36.4% |
| Q1 2020 | $190,000 | -4.5% | 4,525 | +3.1% | 0.01% | +22.2% |
| Q4 2019 | $199,000 | +5.3% | 4,389 | +6.0% | 0.01% | 0.0% |
| Q3 2019 | $189,000 | -22.2% | 4,139 | 0.0% | 0.01% | -18.2% |
| Q2 2019 | $243,000 | +30.6% | 4,139 | 0.0% | 0.01% | +22.2% |
| Q1 2019 | $186,000 | +15.5% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $161,000 | -15.3% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $190,000 | +5.6% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $180,000 | +11.8% | 4,139 | +1.4% | 0.01% | +12.5% |
| Q1 2018 | $161,000 | +41.2% | 4,080 | +21.8% | 0.01% | +60.0% |
| Q4 2017 | $114,000 | +93.2% | 3,350 | +29.4% | 0.01% | +66.7% |
| Q3 2017 | $59,000 | +34.1% | 2,588 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $44,000 | – | 2,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |